ReviewFrontiers in cell and developmental biology2024

Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects.

Mehdi Alidadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.